Arteriit Khortona kak prichina likhoradki neyasnogo geneza u pozhilogo bol'nogo


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In the structure of causes of fever of unknown origin in elderly, rheumatic diseases are one of the leading cause, unless infectious diseases and cancer. In turn, Horton’s arteritis (giant-cell arteritis, temporal arteritis) plays a special role among rheumatic diseases, because it is the most common vasculitis of elderly people. The combination of inflammatory blood changes and the newly appeared headache involves a wide diagnostic search, while this combination of symptoms is indicative of the presence of temporal arteritis. The clinical observation of patient with temporal arteritis, who was observed for a long time with diagnosis of fever of unknown origin, as well as an overview of the literature on the diagnosis and treatment of Horton's arteritis are presented.

Full Text

Restricted Access

References

  1. United Nations. Dept. of Economic and Social Affairs. Population Division., Replacement migration : is it a solution to declining and ageing populations. New York: United Nations, 2001:151.
  2. Nakasato Y. Geriatric rheumatology: a comprehensive approach. New York: Springer, 2011.
  3. Bugeja G, Kumar A, Banerjee AK. Exclusion o f elderly people from clinical research: a descriptive study of published reports. BMJ1997;315(7115):1059.
  4. Burkhardt H, Wehling M. Difficulties in pharmacotherapy of the elderly. Internist (Berl) 2010;51(6):737-47;quiz 748.
  5. Knockaert DC, Vanneste LJ, Bobbaers HJ. Fever of unknown origin in elderly patients. J Am Geriatr Soc 1993;41( 11): 1187-92.
  6. Hunder GG. Epidemiology of giant-cell arteritis. Cleve Clin J Med2002;69(2):SII79-82.
  7. Tal S, Guller V, Gurevich A. Fever of unknown origin in older adults. Clin Geriatr Med 2007; 23(3):649-68.
  8. Barrier J, Schneebeli S, Peltier P. Les fievres pro-longuees inexpliquees chez les personnes agees. Concours Med 1982; 104:4679-89.
  9. Esposito AL, Gleckman RA. Fever of unknown origin in the elderly. J Am Geriatr Soc 1978;26( 11):498-505.
  10. Семенкова Е.Н. Системные васкулиты. М., 1988. 240 c.
  11. Reinisch VM, et al. Headache in the elderly. Schmerz 2008;22(1):22-30.
  12. Gobel H, Heinze A. Headache and facial pain in the elderly. Schmerz 2007;21(6):561-9; quiz 570-71.
  13. Hunder GG, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33(8):1122-28.
  14. Salvarani C, et al. Polymyalgia rheumatica and giant cell arteritis: a 5 -year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987;5(3):205-15.
  15. Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum 1981 ;24( 11):1414-18.
  16. Aiello PD, et al. Visual prognosis in giant cell arteritis. Ophthalmology 1993;100(4):550-55.
  17. Gonzalez- Gay MA, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 1998;41 (8): 1497-504.
  18. Gonzalez-Gay MA, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000;79(5):283-92.
  19. Новиков П.И. и др. Синдром Такаясу при болезни Хортона // Клин. мед. 2010. № 3. С. 70-4.
  20. Hoffman GS, et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002;46(5):1309-18.
  21. Jover, JA, et al., Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;134(2):106-14.
  22. Spiera RF, et al. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 2001;19(5): 495-501.
  23. Mahr AD, et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 2007;56(8):2789-97.
  24. Schmidt WA, et al. Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford), 2008;47(9): 1406-408.
  25. Liu GT, et al. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 1994;101(11): 1779-85.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies